Industry Growth Insights published a new data on “Precision Cancer Diagnostic Tests Market”. The research report is titled “Precision Cancer Diagnostic Tests Market research by Types (Imaging, Molecular, Histology/Cytology, Tumor Marker Immunoassays, POC Colon Cancer Tests), By Applications (Hospital, Clinic, Other), By Players/Companies Abbott Laboratories, Agilent Technologies, Becton Dickinson and Company, Bio-Rad Laboratories, Biocartis N.V., Biocept, bioMerieux SA, Canon Medical Systems Corporation, Cynvenio Biosystems, Danaher Corporation, Epigenomics AG, Exosome Diagnostics, Foundation Medicine, General Electric Company, Genomic Health, Hologic, Illumina, Menarini Silicon Biosystems SpA, Myriad Genetics, NanoString Technologies, Ortho Clinical Diagnostics, QIAGEN N.V., Randox Laboratories Ltd., Roche Holding AG, Royal Philips N.V., Siemens AG, Thermo Fisher Scientific, Vela Diagnostics”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Precision Cancer Diagnostic Tests Market Research Report
By Type
Imaging, Molecular, Histology/Cytology, Tumor Marker Immunoassays, POC Colon Cancer Tests
By Application
Hospital, Clinic, Other
By Companies
Abbott Laboratories, Agilent Technologies, Becton Dickinson and Company, Bio-Rad Laboratories, Biocartis N.V., Biocept, bioMerieux SA, Canon Medical Systems Corporation, Cynvenio Biosystems, Danaher Corporation, Epigenomics AG, Exosome Diagnostics, Foundation Medicine, General Electric Company, Genomic Health, Hologic, Illumina, Menarini Silicon Biosystems SpA, Myriad Genetics, NanoString Technologies, Ortho Clinical Diagnostics, QIAGEN N.V., Randox Laboratories Ltd., Roche Holding AG, Royal Philips N.V., Siemens AG, Thermo Fisher Scientific, Vela Diagnostics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
164
Number of Tables & Figures
115
Customization Available
Yes, the report can be customized as per your need.
Global Precision Cancer Diagnostic Tests Market Report Segments:
The global Precision Cancer Diagnostic Tests market is segmented on the basis of:
Types
Imaging, Molecular, Histology/Cytology, Tumor Marker Immunoassays, POC Colon Cancer Tests
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Agilent Technologies
- Becton Dickinson and Company
- Bio-Rad Laboratories
- Biocartis N.V.
- Biocept
- bioMerieux SA
- Canon Medical Systems Corporation
- Cynvenio Biosystems
- Danaher Corporation
- Epigenomics AG
- Exosome Diagnostics
- Foundation Medicine
- General Electric Company
- Genomic Health
- Hologic
- Illumina
- Menarini Silicon Biosystems SpA
- Myriad Genetics
- NanoString Technologies
- Ortho Clinical Diagnostics
- QIAGEN N.V.
- Randox Laboratories Ltd.
- Roche Holding AG
- Royal Philips N.V.
- Siemens AG
- Thermo Fisher Scientific
- Vela Diagnostics
Highlights of The Precision Cancer Diagnostic Tests Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Imaging
- Molecular
- Histology/Cytology
- Tumor Marker Immunoassays
- POC Colon Cancer Tests
- By Application:
- Hospital
- Clinic
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Precision Cancer Diagnostic Tests Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Precision cancer diagnostic tests are medical procedures that can help doctors determine the precise location and type of cancer in a patient. These tests can be used to diagnose cancers early, when they are more treatable.
Some of the major players in the precision cancer diagnostic tests market are Abbott Laboratories, Agilent Technologies, Becton Dickinson and Company, Bio-Rad Laboratories, Biocartis N.V., Biocept, bioMerieux SA, Canon Medical Systems Corporation, Cynvenio Biosystems, Danaher Corporation, Epigenomics AG, Exosome Diagnostics, Foundation Medicine, General Electric Company, Genomic Health, Hologic, Illumina, Menarini Silicon Biosystems SpA, Myriad Genetics, NanoString Technologies, Ortho Clinical Diagnostics, QIAGEN N.V., Randox Laboratories Ltd., Roche Holding AG, Royal Philips N.V., Siemens AG, Thermo Fisher Scientific, Vela Diagnostics.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Precision Cancer Diagnostic Tests Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Precision Cancer Diagnostic Tests Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Precision Cancer Diagnostic Tests Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Precision Cancer Diagnostic Tests Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Precision Cancer Diagnostic Tests Market Size & Forecast, 2018-2028 4.5.1 Precision Cancer Diagnostic Tests Market Size and Y-o-Y Growth 4.5.2 Precision Cancer Diagnostic Tests Market Absolute $ Opportunity
Chapter 5 Global Precision Cancer Diagnostic Tests Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Precision Cancer Diagnostic Tests Market Size Forecast by Type
5.2.1 Imaging
5.2.2 Molecular
5.2.3 Histology/Cytology
5.2.4 Tumor Marker Immunoassays
5.2.5 POC Colon Cancer Tests
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Precision Cancer Diagnostic Tests Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Precision Cancer Diagnostic Tests Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Precision Cancer Diagnostic Tests Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Precision Cancer Diagnostic Tests Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Precision Cancer Diagnostic Tests Analysis and Forecast
9.1 Introduction
9.2 North America Precision Cancer Diagnostic Tests Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Precision Cancer Diagnostic Tests Market Size Forecast by Type
9.6.1 Imaging
9.6.2 Molecular
9.6.3 Histology/Cytology
9.6.4 Tumor Marker Immunoassays
9.6.5 POC Colon Cancer Tests
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Precision Cancer Diagnostic Tests Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Precision Cancer Diagnostic Tests Analysis and Forecast
10.1 Introduction
10.2 Europe Precision Cancer Diagnostic Tests Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Precision Cancer Diagnostic Tests Market Size Forecast by Type
10.6.1 Imaging
10.6.2 Molecular
10.6.3 Histology/Cytology
10.6.4 Tumor Marker Immunoassays
10.6.5 POC Colon Cancer Tests
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Precision Cancer Diagnostic Tests Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Precision Cancer Diagnostic Tests Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Precision Cancer Diagnostic Tests Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Precision Cancer Diagnostic Tests Market Size Forecast by Type
11.6.1 Imaging
11.6.2 Molecular
11.6.3 Histology/Cytology
11.6.4 Tumor Marker Immunoassays
11.6.5 POC Colon Cancer Tests
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Precision Cancer Diagnostic Tests Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Precision Cancer Diagnostic Tests Analysis and Forecast
12.1 Introduction
12.2 Latin America Precision Cancer Diagnostic Tests Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Precision Cancer Diagnostic Tests Market Size Forecast by Type
12.6.1 Imaging
12.6.2 Molecular
12.6.3 Histology/Cytology
12.6.4 Tumor Marker Immunoassays
12.6.5 POC Colon Cancer Tests
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Precision Cancer Diagnostic Tests Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Precision Cancer Diagnostic Tests Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Precision Cancer Diagnostic Tests Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Precision Cancer Diagnostic Tests Market Size Forecast by Type
13.6.1 Imaging
13.6.2 Molecular
13.6.3 Histology/Cytology
13.6.4 Tumor Marker Immunoassays
13.6.5 POC Colon Cancer Tests
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Precision Cancer Diagnostic Tests Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Precision Cancer Diagnostic Tests Market: Competitive Dashboard
14.2 Global Precision Cancer Diagnostic Tests Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboratories
14.3.2 Agilent Technologies
14.3.3 Becton Dickinson and Company
14.3.4 Bio-Rad Laboratories
14.3.5 Biocartis N.V.
14.3.6 Biocept
14.3.7 bioMerieux SA
14.3.8 Canon Medical Systems Corporation
14.3.9 Cynvenio Biosystems
14.3.10 Danaher Corporation
14.3.11 Epigenomics AG
14.3.12 Exosome Diagnostics
14.3.13 Foundation Medicine
14.3.14 General Electric Company
14.3.15 Genomic Health
14.3.16 Hologic
14.3.17 Illumina
14.3.18 Menarini Silicon Biosystems SpA
14.3.19 Myriad Genetics
14.3.20 NanoString Technologies
14.3.21 Ortho Clinical Diagnostics
14.3.22 QIAGEN N.V.
14.3.23 Randox Laboratories Ltd.
14.3.24 Roche Holding AG
14.3.25 Royal Philips N.V.
14.3.26 Siemens AG
14.3.27 Thermo Fisher Scientific
14.3.28 Vela Diagnostics